An IRB determines that a clinical trial of an investigational device is a nonsignificant risk trial. Which of the following best describes a distinguishing characteristic of a non-significant risk trial? Study is considered a minimal risk study. FDA will use the information in order to classify the device. Sponsor can initiate the study at that organization without first submitting an IDE to the FDA. Investigator can conduct the study without obtaining the subject’s signature on a consent form.
[Expert Solution]: An IRB determines that a clinical trial of an…
Need help with your Clinical Case Studies case study or NCLEX preparation? Connect with a verified Nursing expert now.